This study examined the impact of a pregabalin step therapy policy on utilization and medical costs in Humana’s Medicare and commercial plans.
For patients who use biologic treatments for rheumatoid arthritis, specialty pharmacy care yields higher medication adherence and lower medical costs than retail pharmacy care.
Pharmacist-delivered medication therapy management is a cost-effective method for increasing the utilization of guideline-recommended cardiovascular therapies in high-risk diabetic Medicare patients.
A data-centric approach is vital for patients with complex conditions, particularly in determining what has worked well and anticipating what medical or pharmacy care is required for effective outcomes in the future.
Telepharmacy is comparable to usual care in transitioning members new to an HMO onto formulary medications.
Many patients with T2D will require insulin therapy; however, these patients are also likely to develop insulin resistance over time.
This Continuing Education activity is supported by educational grants from Sanofi-Aventis US Genzyme and Novartis Pharmaceuticals Corporation.
With the current increase in pharmacy school enrollment contributing to a more competitive job market, novel and nontraditional career paths may become a more viable option for pharmacy school graduates.
There are a multitude of reasons why pharmacy students choose to pursue a career in specialty pharmacy.
To get the right drug in the right amount at the right time to the patient in the most cost-effective manner, the following strategies must be used.
With over 30 million Americans suffering from migraines, health care professionals are constantly searching for new alternatives to eliminate the disabling pain for patients.
Evaluation of a therapeutic substitution from atorvastatin to simvastatin on low-density lipoprotein control, and assessment of program participation rates for a commercially insured population.
Patients on this therapy should monitor their INR frequently, especially when adding other medications.
Teprotumumab is the first fully human IgG1 monoclonal antibody approved by the FDA for the treatment of thyroid eye disease at its source not just reducing the symptoms.
The launch of a second Remicade biosimilar could open the floodgates to biosimilar competition in the specialty drug market.
Electronic prior authorization may enhance support for a value-based pharmaceutical market.
Two speakers faced off during a session at the 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences in Glasgow, Scotland, about whether these products have merit.
The California Board of Pharmacy has authorized multiple waivers of specific provisions of pharmacy law, several of which have had major implications for pharmacy technicians and their scope of practice.
Study assesses the safety and tolerability of TH-302 in combination with dexamethasone.
The generic marketplace remains dynamic and complicated, as patent expirations,interest in biosimilars, and international competition spur major changes.
Hub services act to simplify the complexity and perform as an intermediary between involved parties.
Independent specialty pharmacies foster the development of innovative services and programs that demonstrate a patient-centric approach and an entrepreneurial business philosophy.